Cornercap Investment Counsel’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Cornercap Investment Counsel's AMGN Position: Q2 2023 in Review
Cornercap Investment Counsel sold out of Amgen (AMGN) in Q2 2023, closing a stake of 9,028 shares — an estimated $2.18M sold.
Cornercap Investment Counsel first reported a position in AMGN in Q3 2015 and held it in 27 quarters. The position peaked at $7.46M in Q3 2018. 2,390 funds tracked by Wall St. Rank hold AMGN as of Q2 2023.
- Cornercap Investment Counsel reported no remaining Amgen position as of Q2 2023 after selling out during the quarter.
- Cornercap Investment Counsel sold 9,028 Amgen shares in Q2 2023, an estimated $2.18M.
- Cornercap Investment Counsel first reported a position in Amgen in Q3 2015 and held it in 27 quarters.
- Cornercap Investment Counsel's Amgen position peaked at $7.46M in Q3 2018.
- 2,390 funds tracked by Wall St. Rank held Amgen as of Q2 2023.
Based on Cornercap Investment Counsel's 13F filing for Q2 2023, filed 11 Aug 2023.